BUPRENORPHINE HCL SL, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054017613.

FDA Drug Recall #D-796-2014 — Class II — July 2, 2013

Recall Summary

Recall Number D-796-2014
Classification Class II — Moderate risk
Date Initiated July 2, 2013
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Aidapak Services, LLC
Location Vancouver, WA
Product Type Drugs
Quantity 60 Tablets

Product Description

BUPRENORPHINE HCL SL, Tablet, 2 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00054017613.

Reason for Recall

Labeling: Label Mixup: BUPRENORPHINE HCL SL, Tablet, 2 mg may be potentially mislabeled as one of the following drugs: DOCUSATE SODIUM, Capsule, 250 mg, NDC 00904789159, Pedigree: AD37072_4, EXP: 5/13/2014; MAGNESIUM CHLORIDE DR, Tablet, 64 mg, NDC 00904791152, Pedigree: AD54510_1, EXP: 2/28/2014.

Distribution Pattern

Repacked drugs were distributed in Arizona, California, Oregon, and Washington.

Lot / Code Information

BUPRENORPHINE HCL SL, Tablet, 2 mg has the following codes: Pedigree: AD39573_1, EXP: 5/13/2014; Pedigree: AD54478_1, EXP: 5/20/2014.

Other Recalls from Aidapak Services, LLC

Recall # Classification Product Date
D-799-2014 Class II MERCapsuleTOPURINE, Tablet, 50 mg, Rx only, Dis... Jul 2, 2013
D-1029-2014 Class II SELENIUM, Tablet, 50 mcg, Over The Counter, Dis... Jul 2, 2013
D-487-2014 Class II CHOLECALCIFEROL, Capsule, 5000 units, Over The ... Jul 2, 2013
D-847-2014 Class II VENLAFAXINE HCL, Tablet, 100 mg, Rx only, Distr... Jul 2, 2013
D-526-2014 Class II hydrALAZINE HCl Tablet, 100 mg, Rx only, Distri... Jul 2, 2013

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.